Study of Chemotherapy in Combination With All-trans Retinoic Acid (ATRA) With or Without Gemtuzumab Ozogamicin in Patients With Acute Myeloid Leukemia (AML) and Mutant Nucleophosmin-1 (NPM1) Gene Mutation

NCT00893399 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

600

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Gemtuzumab Ozogamicin (Mylotarg)
DRUG: standard chemotherapy

Sponsor

University of Ulm